Research article · 6 Nov 2025
Research articlePublished 2014
Hashimotoand#8217;s Thyroiditis and Nodular Pathology: A Prospective Study in 227 Subjects
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The association between Hashimoto’s Thyroiditis (HT) and Papillary Thyroid Carcinoma (PTC) remains controversial. The aim of this prospective study is to determine if there is a risk to develop a thyroid carcinoma in subjects affected by nodular pathology and HT. Methods: 227 subjects (192 females and 35 males) affected by thyroid nodular pathology were submitted to FNAB (Fine Needle Agobiopsy) to define the cytology of the nodules. TSH, and serum anti-thyroid antibodies were measured. If they had positive serum anti-thyroglobulin (Ab anti-TG) and/or anti-thyroperoxidase (Ab anti-TPO) antibodies and had a TSH <4 uUml were included in the study and they were defined as patient affected by autoimmune thyroiditis (HT) in euthyroidism. No patients assumed substitutive therapy with l-thyroxine. All patients gave their informed consent to the study. The patients were classified in 2 groups: Group A: 103 patients (mean age 55.2 ± 13.2 years, 91.3% females, 8.7% males) affected by HT and Group B: 124 patients (mean age 59.3 ± 13.3 years, 79% females and 21% males) without thyroiditis. Results: The nodular pathology is more represented, as attended, in females (91,3% vs. 8,7% in Group A and 79% vs. 21% in Group B). TSH levels were different between Group A and Group B (2.9 vs. 1.5 μUI/ml, p<0.001) but they were similar in patients with or without thyroid carcinoma (3.1 vs. 2.3, p=0.3). The benign pathology was diagnosed in the 94.2% in the Group A and in the 96% in the Group B whereas the malignant nodular pathology was present in the 5.8% in the group A and in the 4% in the Group B without any significant statistical difference. Conclusion: Our study suggests that the associationof HT and nodular pathology do not represent a risk to develop a thyroid carcinoma.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Thyroid Disorders & Therapy.
Case report · 18 Jan 2025
Teprotumumab's Efficacy for Recurrent Severe Thyroid Eye Disease Post-Tocilizumab and Steroid Therapy
Short communication · 26 Dec 2024
Thyroid Dysfunction and Its Correlation with Gut Microbiota Dysbiosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Thyroid Disorders & Therapy
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Ciampolillo A”
- BylineArticles whose byline prints “Barbaro M”
- BylineArticles whose byline prints “Di Trani A”
- BylineArticles whose byline prints “Patruno P”
- BylineArticles whose byline prints “Giorgino F”
